We are honored to have received the endorsements of the organizations and individuals below. Endorsements, such as these, lend credence to our dedication to developing the most advanced and scientifically sound products and treatments in the biopharmaceutical and cosmeceutical industry.
- Mark Weis, MD– Dr. Weis has twenty years of experience in the medical field, including working with Walter Reed Hospital in Washington, DC. A graduate of the University of Kansas Medical School, he has provided consultation services to pharmaceutical industry and continuing medical education industries, in addition to his duties as a primary care physician and medical director. Dr. Weis is currently the CEO of Fountain of Youth, MD, a practice that provides better aging partnerships with physicians and chiropractors. Dr. Weis is also a writer and
- Rollout and expand commercialization of Bellapulse.
Commercialization of Bellapulse will rollout to include the European Union, in addition to the United States and North America.
- Advance our developing products and technologies.
We intend to advance our pipeline of product and technology candidates independently or through licensing, collaborations or other opportunities.
- Maintain research and development capabilities to advance our pipeline.
Our technologies, our cosmeceutical discovery infrastructure, and the integrated approach to research used by our scientists have allowed us to identify and develop a number of targets and novel compounds. We intend to maintain our research and development capabilities to selectively advance our programs and to discover additional cosmetic applications and technologies.